Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 16,704 | 16,162 | 8,831 | 10,537 | 9,127 |
| Operating Income | -16,704 | -16,162 | -8,831 | -10,537 | -9,127 |
| Other Income | 2,988 | 575 | 429 | 21 | 24 |
| Pre-tax Income | -13,717 | -15,586 | -8,402 | -10,516 | -9,103 |
| Net Income Continuous | -13,717 | -15,586 | -8,402 | -10,516 | -9,103 |
| Net Income | $-13,717 | $-15,586 | $-8,402 | $-10,516 | $-9,103 |
| EPS Basic Total Ops | -1.85 | -4.11 | -3.04 | -4.15 | -3.65 |
| EPS Basic Continuous Ops | -1.85 | -4.11 | -3.04 | -4.13 | -3.65 |
| EPS Diluted Total Ops | -1.85 | -4.11 | -3.04 | -4.15 | -3.65 |
| EPS Diluted Continuous Ops | -1.85 | -4.11 | -3.04 | -4.13 | -3.65 |
| EPS Diluted Before Non-Recurring Items | N/A | -4.11 | -3.05 | -4.15 | -3.65 |
| EBITDA(a) | $-17,421 | $-16,171 | $-8,831 | $-10,537 | $-9,127 |